Literature DB >> 23155231

Protein kinase C regulates bombesin-induced rapid VEGF secretion in neuroblastoma cells.

Cameron Schlegel1, Pritha Paul, Sora Lee, Kwang Woon Kim, Nadja Colon, Jingbo Qiao, Dai H Chung.   

Abstract

BACKGROUND: Intracellular signaling responsible for gastrin-releasing peptide (GRP) receptor-mediated neovascularization is not clearly understood. We sought to determine the cellular mechanisms involved in the GRP receptor regulation of vascular endothelial growth factor (VEGF) release in neuroblastoma cells.
MATERIALS AND METHODS: BE(2)-C cells were treated with bombesin (BBS), the amphibian equivalent of GRP, Phorbol myristate acetate (PMA) a PKC agonist, or GF109293X (GFX), and analyses were performed for VEGF secretion, phosphorylated protein kinase B (AKT), extracellular signal-regulated kinases (ERK) and protein kinase D (PKD) expression.
RESULTS: BBS rapidly increased VEGF secretion at 30 min. Pre-treatment with PMA alone produced similar results; this effect was synergistic with the addition of GRP. Conversely, GFX blocked PMA-stimulated increase in VEGF secretion. Immunofluorescent staining for VEGF correlated to BBS, PMA and GFX.
CONCLUSION: PKC is critically responsible for rapid VEGF secretion by GRP receptor signaling in neuroblastoma cells. Inhibition of VEGF significantly reduced GRP-mediated cell proliferation, suggesting its crucial role in neuroblastoma tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23155231      PMCID: PMC3668683     

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  18 in total

1.  Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid.

Authors:  Matthew F W Gee; Rika Tsuchida; Claudia Eichler-Jonsson; Bikul Das; Sylvain Baruchel; David Malkin
Journal:  Oncogene       Date:  2005-12-01       Impact factor: 9.867

2.  Increased isoform-specific membrane translocation of conventional and novel protein kinase C in human neuroblastoma SH-SY5Y cells following prolonged hypoxia.

Authors:  Junfa Li; Yanming Qu; Pengyu Zu; Song Han; Ge Gao; Qunyuan Xu; Li Fang
Journal:  Brain Res       Date:  2006-05-08       Impact factor: 3.252

3.  Multiple protein kinase pathways are involved in gastrin-releasing peptide receptor-regulated secretion.

Authors:  M R Hellmich; K L Ives; V Udupi; M S Soloff; G H Greeley; B N Christensen; C M Townsend
Journal:  J Biol Chem       Date:  1999-08-20       Impact factor: 5.157

4.  Role of protein kinase C isoforms in phorbol ester-induced vascular endothelial growth factor expression in human glioblastoma cells.

Authors:  S C Shih; A Mullen; K Abrams; D Mukhopadhyay; K P Claffey
Journal:  J Biol Chem       Date:  1999-05-28       Impact factor: 5.157

Review 5.  Molecular biology of neuroblastoma.

Authors:  J M Maris; K K Matthay
Journal:  J Clin Oncol       Date:  1999-07       Impact factor: 44.544

6.  Bombesin induces angiogenesis and neuroblastoma growth.

Authors:  Junghee Kang; Titilope A Ishola; Naira Baregamian; Joshua M Mourot; Piotr G Rychahou; B Mark Evers; Dai H Chung
Journal:  Cancer Lett       Date:  2007-03-26       Impact factor: 8.679

7.  N-myc is a novel regulator of PI3K-mediated VEGF expression in neuroblastoma.

Authors:  J Kang; P G Rychahou; T A Ishola; J M Mourot; B M Evers; D H Chung
Journal:  Oncogene       Date:  2008-02-18       Impact factor: 9.867

Review 8.  Gastrin-releasing peptide and cancer.

Authors:  Oneel Patel; Arthur Shulkes; Graham S Baldwin
Journal:  Biochim Biophys Acta       Date:  2006-01-31

9.  Bevacizumab suppresses neuroblastoma progression in the setting of minimal disease.

Authors:  Thomas L Sims; Regan F Williams; Cathy Y Ng; Shannon F Rosati; Yunyu Spence; Andrew M Davidoff
Journal:  Surgery       Date:  2008-08       Impact factor: 3.982

10.  Bevacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy.

Authors:  Paxton V Dickson; John B Hamner; Thomas L Sims; Charles H Fraga; Catherine Y C Ng; Surender Rajasekeran; Nikolaus L Hagedorn; M Beth McCarville; Clinton F Stewart; Andrew M Davidoff
Journal:  Clin Cancer Res       Date:  2007-07-01       Impact factor: 12.531

View more
  2 in total

Review 1.  Bombesin Receptor Family Activation and CNS/Neural Tumors: Review of Evidence Supporting Possible Role for Novel Targeted Therapy.

Authors:  Terry W Moody; Lingaku Lee; Irene Ramos-Alvarez; Tatiana Iordanskaia; Samuel A Mantey; Robert T Jensen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-01       Impact factor: 5.555

2.  Epithelial Membrane Protein-2 (EMP2) Antibody Blockade Reduces Corneal Neovascularization in an In Vivo Model.

Authors:  Michel M Sun; Ann M Chan; Samuel M Law; Sergio Duarte; Daniel Diaz-Aguilar; Madhuri Wadehra; Lynn K Gordon
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-01-02       Impact factor: 4.799

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.